Damae Medical

Paris, France · Founded 2014 · $27.8M raised

Headquarters
Paris
Employees
11–50
Founded
2014
Business Model
B2B
Total Funding
$27.8M
Last Round
$5.7M SeedNov 2025
Rounds
3

About

Damae Medical is a Paris-based medtech company founded in 2014 as a spin-off from the University of Paris-Saclay, specializing in non-invasive skin imaging for cancer detection. The company developed deepLive™, a handheld medical imaging device based on LC-OCT (Line-field Confocal Optical Coherence Tomography) technology that provides 3D cellular-resolution imaging of skin tissue in vivo, enabling dermatologists to perform digital biopsies without cutting. deepLive™ received CE Mark Class IIA under EU MDR in 2023 and FDA 510(k) clearance in March 2025, and has been deployed in over 10 countries across Europe, Japan, Australia, and the United States. The company has raised over €27M including a €15M Series B in 2025 led by Creadev.

Summary

Damae Medical is a Biotech company based in Paris, France, founded in 2014. It has raised $27.8M in total across 3 rounds, most recently a $5.7M Seed round in Nov 2025. Investors include Creadev, Partech and Kurma Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BNov 2025
$16.3M

Sign up to see all 3 rounds

Seed through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Damae Medical on Indexed.vc
<a href="https://indexed.vc/companies/damae-medical"><img src="https://indexed.vc/api/badge/company/damae-medical" alt="Damae Medical on Indexed.vc" width="260" height="76" /></a>